Hepatocellular carcinoma (HCC) – a role of surgical resection and liver transplantation for the treatment of HCC
Journal Title: Postępy Nauk Medycznych - Year 2010, Vol 23, Issue 1
Abstract
Hepatocellular carcinoma (HCC) is one of the common malignant tumors worldwide and is the fifth leading cause of death on a worldwide basis. The major risk factors for development of HCC are now well defined: cirrhosis, regardless of etiology, chronic viral hepatitis B,C and D, toxins and drugs(e.g. alcohol, aflatoxins, anabolic steroids) and metabolic liver diseases (e.g., hereditary hemochromatosis, alfa1-antitrypsin deficiency). Clinical presentation is not typical and different, depending on stage at discovery, and hepatic dysfunction, and the geographic location of the patient. Routine imaging with USG, CT scan and MRI is the diagnostic procedure and follow abnormal laboratory tests. Many centers employed the screening protocol(AFP test, ultrasound) to detect and to determine the stage cancer early. This strategy allow selection of optimal treatment procedure and reduce mortality. The optimal treatment for HCC is surgical resection with the curative intent. Percutaneous ethanol injection has been widely performed as an alternative to surgery in patients with small HCCs. Radiofrequency ablation produces thermal destruction with an electric current that passes to the tumor via electrode tip, resulting in heat generation and coagulative necrosis. Transcatheter arterial chemoembolisation is one of the popular and effective treatments for patients with unresectable HCC. Targeted therapy ( monoclonal antybodies, receptor kinase inhibitors) may inhibits tumor progression. Liver transplantation is an therapeutic option in patients with HCC. The treatment of HCC by liver transplantation has evolved during decades in term to determine the best criteria of patients selection and optimal treatment protocols pre- and posttransplantation. Preoperative diagnostic should be as extensive as needed to accurately assess the morphological and biological characteristics of tumor – criteria for transplant candidacy. Adjuvant chemotherapy is a part of treatment protocols in many centers. It is evident from the published results that liver transplantation is the best chance for cure in patients with early HCC. The important factor in reducing of metastatic disease occurrence after ltx is optimal immunosuppressive regimen. The further efforts should be made to improve the results of liver transplantation.
Authors and Affiliations
Marek Krawczyk, Urszula Ołdakowska-Jedynak
Keywords
Related Articles
- EP ID EP53737
- DOI -
- Views 203
- Downloads 0
Hereditary breast and ovarian cancer
Familial breast cancer was first recognized in the Roman medical literature of 100 AD (1). The first documentation of familial clustering of breast cancer in modern times was published by Broca, who reported 10 cases of...
Leczenie żylaków powrózka nasiennego metodą wewnątrznaczyniową
<b>Cel pracy. </b>Retrospektywna ocena skuteczności leczenia żylaków powrózka nasiennego metodą embolizacji wewnątrznaczyniowej wolnymi spiralami z jednoczesnym zastosowaniem aetoxysclerorlu.&...
The usefulness of determining C-reactive protein by using rapid test for the differentiation of infections in febrile children
Introduction. An ill child in the Hospital Emergency Department (HED) is a major diagnostic and therapeutic challenge. Serum levels of C-reactive protein (CRP), in correlation with the clinical condition of the patient,...
Ekspresja genów kodujących transformujący czynnik wzrostowy β1 i jego receptory u chorych z twardziną układową i objawem Raynauda
<b>Wprowadzenie. </b>Rolę TGFβ1 w patogenezie twardziny układowej (ang. <i>systemic sclerosis</i> – SSc) wykazano we wcześniejszych badan...
Nawrót choroby nowotworowej o dramatycznym przebiegu u pacjentki po przeszczepieniu nerki – analiza problemu nawrotu nowotworu po transplantacji i opis przypadku
Choroby nowotworowe są obok chorób układu sercowo-naczyniowego i zakażeń główną przyczyną zgonów pacjentów po przeszczepieniu narządu unaczynionego. Po transplantacji najczęściej rozwijają się nowotwory de novo, znacznie...